Poietis

Poietis is a private, commercial-stage company offering a differentiated bioprinting platform centered on its proprietary Laser-Assisted Bioprinting (LAB) technology. The company targets two primary markets with its modular NGB platform: the NGB-R™ for academic and pharmaceutical research, and the NGB-C™, a GMP-compliant system designed for clinical production of implantable tissues. Poietis operates at the intersection of advanced manufacturing and regenerative medicine, aiming to enable the transition from basic research to therapeutic tissue fabrication. Its value proposition lies in high-resolution, automated bioprinting that supports the creation of biologically relevant and complex tissue constructs.

Laser-Assisted Bioprinting (LAB) technology enabling high-precision, high-viability deposition of cells and bioinks via a robotic platform (NGB). The platform is modular, with research (NGB-R) and GMP-compliant clinical (NGB-C) versions.

Poietis competes in the bioprinting market against companies using extrusion (e.g., CELLINK/BICO, Allevi), inkjet (e.g., Organovo historically), and other technologies. Its Laser-Assisted Bioprinting differentiates it on resolution and cell viability, positioning it in a premium segment. Competitors for the clinical-grade system include established medical device companies developing tissue engineering solutions.